Infinity Pharmaceuticals Inc (OTC Pink - Limited Information:INFIQ)
| 0.0037 Delayed Data As of 12:00am ET |  +0.00062 / +20.00%Today’s Change | 0.00 Today|||52-Week Range 0.77 | -99.33% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -128.4M | -30.1M | -41.8M | -11.3M | |
| Depreciation | 2.3M | 3.4M | 1.7M | 191.0K | ||
| Total Other Cash Flow | 15.5M | -98.5M | 14.1M | 3.6M | ||
| Funds From Operations | -110.6M | -125.1M | -26.0M | -7.5M | ||
| Funds From/For Other Operating Expenses | -27.0M | 29.2M | 10.7M | -2.8M | ||
| Net Cash Flow - Operating Activities | -83.7M | -154.4M | -36.7M | -4.7M | ||
| Investing | Increase In Investments | -121.5M | -66.5M | -24.0M | -15.7M | |
| Decrease In Investments | 90.0M | 105.4M | 19.0M | 28.8M | ||
| Capital Expenditures | -6.4M | -661.0K | -43.0K | 0.00 | ||
| Fixed Asset Disposal | -- | 2.1M | 750.0K | 0.00 | ||
| Net Cash Flow Investing | -37.9M | 40.3M | -4.3M | 13.1M | ||
| Financing | Short Term Borrowings | -- | 0.00 | 0.00 | -4.0M | |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | -236.0K | -415.0K | -292.0K | 0.00 | ||
| Net Proceeds Stock Sale | 2.8M | 332.0K | 146.0K | 9.6M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | -- | 0.00 | 1.7M | 0.00 | ||
| Other Uses - Financing | 273.0K | 0.00 | 0.00 | 0.00 | ||
| Net Cash Flow - Financing | 2.3M | -83.0K | 1.5M | 5.6M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -119.2M | -114.1M | -39.5M | 14.0M | ||
